Frances Hall

1.7k total citations
15 papers, 294 citations indexed

About

Frances Hall is a scholar working on Pathology and Forensic Medicine, Rheumatology and Immunology. According to data from OpenAlex, Frances Hall has authored 15 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 6 papers in Rheumatology and 5 papers in Immunology. Recurrent topics in Frances Hall's work include Systemic Sclerosis and Related Diseases (5 papers), Systemic Lupus Erythematosus Research (4 papers) and T-cell and B-cell Immunology (3 papers). Frances Hall is often cited by papers focused on Systemic Sclerosis and Related Diseases (5 papers), Systemic Lupus Erythematosus Research (4 papers) and T-cell and B-cell Immunology (3 papers). Frances Hall collaborates with scholars based in United Kingdom, United States and Belgium. Frances Hall's co-authors include Nicola Dalbeth, J. S. Hill Gaston, Richard Duggleby, Malgosia K. Matyszak, Jane Goodall, Lorna B. Jarvis, Ariane L. Herrick, Eileen Baildam, Michael Hughes and Voon H Ong and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, European Journal of Immunology and Lara D. Veeken.

In The Last Decade

Frances Hall

13 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frances Hall United Kingdom 7 147 100 93 54 35 15 294
Adriana Severino Italy 8 97 0.7× 225 2.3× 80 0.9× 53 1.0× 38 1.1× 11 312
Ildikó Fanny Horváth Hungary 12 177 1.2× 76 0.8× 191 2.1× 52 1.0× 54 1.5× 18 465
Jeannine Günther Germany 5 109 0.7× 151 1.5× 40 0.4× 28 0.5× 50 1.4× 5 274
Jacques‐Eric Gottenberg France 9 107 0.7× 39 0.4× 133 1.4× 22 0.4× 34 1.0× 9 328
Takamichi Yuhara Japan 7 103 0.7× 175 1.8× 108 1.2× 93 1.7× 18 0.5× 14 325
Katie Stewart United States 9 101 0.7× 83 0.8× 99 1.1× 33 0.6× 10 0.3× 14 295
Francisco Javier López-Longo Spain 10 62 0.4× 87 0.9× 123 1.3× 24 0.4× 17 0.5× 15 239
Anna Stochmal Poland 9 73 0.5× 186 1.9× 70 0.8× 88 1.6× 25 0.7× 22 309
Salvatore Lupoli Italy 8 101 0.7× 200 2.0× 106 1.1× 56 1.0× 23 0.7× 12 339
Maresa Carulli United Kingdom 4 146 1.0× 107 1.1× 98 1.1× 27 0.5× 47 1.3× 7 303

Countries citing papers authored by Frances Hall

Since Specialization
Citations

This map shows the geographic impact of Frances Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances Hall more than expected).

Fields of papers citing papers by Frances Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances Hall. The network helps show where Frances Hall may publish in the future.

Co-authorship network of co-authors of Frances Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Frances Hall. A scholar is included among the top collaborators of Frances Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances Hall. Frances Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Davison, Adrian K., Ashma Krishan, Robert P New, et al.. (2024). Development of a measuring app for systemic sclerosis-related digital ulceration (SALVE: Scleroderma App for Lesion VErification). Lara D. Veeken. 63(12). 3297–3305. 3 indexed citations
2.
Tornling, Göran, Charlotte Edenius, John D Pauling, et al.. (2024). A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's. Lara D. Veeken. 64(2). 704–713. 5 indexed citations
3.
Hall, Frances, et al.. (2023). P23 Curing the nail. Rheumatology Advances in Practice. 7(Supplement_2).
4.
Cassia, Matthias, Federico Alberici, Rachel Jones, et al.. (2019). Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. Arthritis & Rheumatology. 71(10). 1670–1680. 20 indexed citations
5.
Hughes, Michael, Voon H Ong, Marina Anderson, et al.. (2015). Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis. Lara D. Veeken. 54(11). 2015–2024. 83 indexed citations
6.
Hadjinicolaou, Andreas V., et al.. (2013). Relationship of CD146 expression to activation of circulating T cells: exploratory studies in healthy donors and patients with connective tissue diseases. Clinical & Experimental Immunology. 174(1). 73–88. 13 indexed citations
7.
Busch, Robert, Andreas V. Hadjinicolaou, & Frances Hall. (2012). Local Activation and Systemic Dysregulation of T Lymphocytes in Sjögren’s Syndrome. Current Pharmaceutical Biotechnology. 13(10). 2009–2021. 6 indexed citations
8.
Malaviya, Anshuman & Frances Hall. (2012). Targeting CVD risk in chronic connective tissue disease.. PubMed. 256(1747). 21–6, 3. 3 indexed citations
9.
Zandi, Michael S., Fausta Catapano, Stella Burns, et al.. (2010). POI06 Rituximab in neuropsychiatric systemic lupus erythematosus: a retrospective study of the Cambridge experience. Journal of Neurology Neurosurgery & Psychiatry. 81(11). e54–e54. 2 indexed citations
10.
Mäki-Petäjä, Kaisa, A. D. Booth, Frances Hall, et al.. (2007). 09.01 EZETIMIBE AND SIMVASTATIN BOTH REDUCE INFLAMMATION, DISEASE ACTIVITY, AORTIC STIFFNESS AND IMPROVE ENDOTHELIAL FUNCTION IN RHEUMATOID ARTHRITIS. Artery Research. 1(S1). S25–S25. 1 indexed citations
11.
Hall, Frances & Nicola Dalbeth. (2005). Disease modification and cardiovascular risk reduction: two sides of the same coin?. Lara D. Veeken. 44(12). 1473–1482. 53 indexed citations
12.
13.
Jarvis, Lorna B., Malgosia K. Matyszak, Richard Duggleby, et al.. (2005). Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function. European Journal of Immunology. 35(10). 2896–2908. 81 indexed citations
14.
Hall, Frances. (2003). Put your heart into the joint benefits of statins!. Arthritis Research. 5(4). 202–202. 3 indexed citations
15.
Hall, Frances, Thomas Krausz, & Mark Walport. (1995). Idiopathic eosinophilic myositis. QJM. 88(8). 581–6. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adriana Severino Breakdown of academic impact, for papers by Ildikó Fanny Horváth Breakdown of academic impact, for papers by Jeannine Günther Breakdown of academic impact, for papers by Jacques‐Eric Gottenberg Breakdown of academic impact, for papers by Takamichi Yuhara Breakdown of academic impact, for papers by Katie Stewart Breakdown of academic impact, for papers by Francisco Javier López-Longo Breakdown of academic impact, for papers by Anna Stochmal Breakdown of academic impact, for papers by Salvatore Lupoli Breakdown of academic impact, for papers by Maresa Carulli
Rankless by CCL
2026